GlycoMar is a biotechnology company discovering and developing products for the healthcare and personal care markets.
Founded in 2005, has an established discovery platform technology based on glycobiology products, which generates valuable intellectual property. The company evaluates the functional properties of its novel glycobiology products to identify the best candidates for development and the best market application, which include pharmaceutical, consumer healthcare, cosmetic and nutraceutical.
GlycoMar is developing novel consumer healthcare products addressing inflammatory disorders such as eczema and rhinitis, and pharmaceutical products that address unmet clinical needs in the treatment of inflammatory diseases such as psoriasis, asthma, and inflammatory bowel disease.
The company is developing cosmetic ingredients for the skincare market and nutraceutical ingredients for the supplements and functional food markets. Our development programme is being carried out both in house and with commercial partners.
GlycoMar seeks to develop its discoveries to generate value through out licensing.